India's Pharmaceutical Exports

Country Profile

Malaysia

Malaysia is a significant market for Indian pharmaceutical exports — $170M in FY 2025–26, with 2.2× growth over the past decade. Medicines accounts for 74% of shipments, with vaccines contributing $2.46M. The compound annual growth rate since FY2015 stands at 7.2%.

🇲🇾 $170M · 2.2× growth since FY2015 · 7.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$170M
Exports FY2025–26 DGCIS
2.2×
Growth FY2015→2026
7.2%
CAGR FY2015→2026
74%
Medicines Share
5
Product Categories Supplied
Malaysia is a significant market for Indian pharmaceutical exports — $170M in FY 2025–26, with 2.2× growth over the past decade. Medicines accounts for 74% of shipments, with vaccines contributing $2.46M. The compound annual growth rate since FY2015 stands at 7.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $125M (73.6%) Medicine Ingredients $29.3M (17.2%) Surgical & Hospital Supplies $8.12M (4.8%) Traditional & Herbal $4.90M (2.9%) Vaccines $2.46M (1.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Malaysia in the RBI overseas direct investment dataset (2011–2026).